Understanding Factors in Prostate Cancer Disparities
This study is looking into why prostate cancer (PC) affects different groups of men unequally, especially Black men who experience higher rates of diagnosis and death. Researchers want to find new social, structural, and lifestyle factors that contribute to these differences. If you've chosen to have a radical prostatectomy (surgery to remove the prostate) for prostate cancer and are part of the Urology Biobank, you might be able to join. The study involves completing online surveys and allowing researchers to review your medical records. The goal is to identify factors that lead to more aggressive prostate cancer in Black, Hispanic, and Asian men, which could help improve screening and treatment decisions. The study aims to identify these factors over a period of up to two years.
- Study design
- This is an observational study, meaning researchers will collect information without giving new treatments. It plans to include about 350 men.
- What's involved
- You would complete online surveys and allow researchers to access your medical records, including your disease history and treatment details.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary goal is to identify factors contributing to prostate cancer over a period of up to two years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Social, Structural, and Lifestyle Drivers of Prostate Cancer Disparities
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Matthew Cooperberg, MD · PRINCIPAL_INVESTIGATOR · University of California, San Francisco
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Identification of not yet identified factors contributing to prostate cancerUp to 2 years
Genomic and SSDH factors will be evaluated to locate not yet identified factors that are associated with greater immune activation and prediction of unfavorable vs. favorable prostate cancer biology by race and ethnicity groups.